Keywords
MedicineIrinotecanOxaliplatinFolinic acidRegimenBolus (digestion)FluorouracilNeutropeniaGastroenterologyMucositisInternal medicineChemotherapySurgeryCancerColorectal cancer
Affiliated Institutions
Related Publications
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
Purpose Immune checkpoint inhibition has been demonstrated to be an effective anticancer strategy. Several lines of evidence support the study of immunotherapy in triple-negativ...
Publication Info
- Year
- 2003
- Type
- article
- Volume
- 14
- Issue
- 3
- Pages
- 481-489
- Citations
- 112
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
112
OpenAlex
Cite This
Marc Ychou,
Thierry Conroy,
Jean‐François Seitz
et al.
(2003).
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors.
Annals of Oncology
, 14
(3)
, 481-489.
https://doi.org/10.1093/annonc/mdg119
Identifiers
- DOI
- 10.1093/annonc/mdg119